Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Metis Therapeutics
Metis Therapeutics

Metis Therapeutics

Series B

METiS Therapeutics: Developing small molecule drugs for diverse illnesses through integrated discovery.

HQ
Cambridge, MA, US
Founded
2017
Overview
Compare
Fundraising
Employees

Founded with a mission to revolutionize drug discovery, METiS Therapeutics leverages cutting-edge technologies to develop novel therapeutics for serious diseases. The company focuses on integrating Artificial Intelligence (AI), Machine Learning (ML), and Molecular Dynamics (MD) to create innovative small molecule drugs, biologics, and advanced nucleic acids. METiS' lead programs utilize AI and high-throughput in vivo screening to discover unique lipid nanoparticles (LNPs) with exceptional targeting capabilities.

Notable figures affiliated with METiS Therapeutics include experts in AI-driven drug discovery and seasoned professionals from the pharmaceutical industry. The company has attracted significant investment from leading venture capital firms, underscoring its potential impact. Key achievements include the development of proprietary LNPs that enhance drug delivery and efficacy. METiS Therapeutics is poised to make a substantial impact on the treatment of serious diseases through its pioneering approach to integrated drug discovery.

Metis Therapeutics - Similar Companies

Metaphore Biotechnologies logo

Metaphore Biotechnologies

metaphorebio.com

Marengo Therapeutics logo

Marengo Therapeutics

marengotx.com

Teon Therapeutics logo

Teon Therapeutics

Exo Therapeutics logo

Exo Therapeutics

Cellarity logo

Cellarity

Xontogeny logo

Xontogeny

xontogeny.com

Ensem Therapeutics logo

Ensem Therapeutics

ensemtx.com

Siolta Therapeutics logo

Siolta Therapeutics

Nextrna Therapeutics logo

Nextrna Therapeutics

Serotiny logo

Serotiny

serotiny.bio

DeepBiome Therapeutics logo

DeepBiome Therapeutics

Vesalius Therapeutics logo

Vesalius Therapeutics

vesaliustx.com

Mati Therapeutics logo

Mati Therapeutics

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Mythic Therapeutics logo

Mythic Therapeutics

mythictx.com

Metis Therapeutics - Quick Facts

Who are Metis Therapeutics' competitors?

Companies similar to Metis Therapeutics include Metaphore Biotechnologies, Marengo Therapeutics, Teon Therapeutics and Exo Therapeutics.

When was Metis Therapeutics founded?

Metis Therapeutics was founded in 2017.

Where is Metis Therapeutics' headquarters located?

Metis Therapeutics' headquarters is located in Cambridge, MA, US.

When was Metis Therapeutics' last funding round?

Metis Therapeutics' most recent funding round was for $75M (USD) in April 2022.

How much has Metis Therapeutics raised to-date?

As of Apr 5, 2022, Metis Therapeutics has raised a total of $261M (USD).

How many employees does Metis Therapeutics have?

Metis Therapeutics has 36 employees as of Feb 4, 2024.

Metis Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • AI Operations
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified